Jump to Navigation
Home

Main menu

  • Home
  • News
  • Markets Map
  • Sentiments
  • Topics
  • Data
  • Comments
  • Images
  • Blog
  • About

Secondary menu

  • Latest News
  • Top Rated
  • Most Popular
  • Archive
  • Discussions
  • Bernanke says Fed likely to reduce bond buying this year
  • Flood washes cars away in India
  • Sensex below 19K, Nifty near 5,700 | Re hits 60/$ |...
  • Floods devastate northern India
  • High FII holding makes pvt banks vulnerable after Fed
  • Top 20 stocks that hit 52-wk low on BSE Midcap index
  • Dotcom decries 'largest data massacre in history...
  • TDSB votes against proposal to charge students $1,500 for...
  • Futures Movers: Oil prices struggle on energy demand, Fed...
  • Ben Bernanke says Fed likely to reduce bond buying this...

    Baxter: This Near 3% Yielder Is Undervalued After 25% Pullback

    Sun, 12/18/2011 - 04:16 EDT - Seeking Alpha
    • BAX
    • Bret Jensen

    By Bret Jensen:Baxter International is down some 25% since its highs this summer. Given its low valuation, steady growth prospects and solid dividend yield; it appears to have sold off too much especially if the market starts to shift into defensive sectors of the market as the contagion in Europe continues. Baxter (BAX) - "Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in two segments, BioScience and Medical Products." (Business description from Yahoo Finance) 7 reasons why Baxter is undervalued at $48 a share:

    1. The stock yields 2.8%. It has also increased its dividend payout at an average 16% clip over the last half decade.
    2. Baxter is selling near the bottom third of its five year valuation range based on P/E, P/S and P/B.
    3. It appears to have

    Complete Story »

    • Original article
    • Login or register to post comments
     

    Related

    • Is Baxter International a Value Investment?

      Bud Labitan submitsBaxter International Inc. (BAX) (Baxter) through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.

    • Baxter International Inc: Fundamental Stock Research Analysis

      By F.A.S.T. Graphs:Before analyzing a company for investment, it's important to have a perspective on how well the business has performed. Because at the end of the day, if you are an investor, you are buying the business. The FAST Graphs™ presented with this article will focus first on the business behind the stock. The orange line on the graph plots earnings per share since 2004. A quick glance vividly reveals the historical operating record of the company.

    • Baxter's A Buy For Growth, Cash Flow, And Rising Dividends

      By Ingrid Hendershot: Baxter International (BAX) makes products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.

    • Baxter International: A Dividend Bioscience Company To Consider

      By David Zanoni:Baxter International (BAX) is a $31.97 billion large-cap manufacturer of products for hemophilia, infectious diseases, immune disorders, kidney diseases, trauma, and other conditions. The company operates in two segments: Bioscience and Medical Products. Baxter distributes its products to doctor's offices, kidney dialysis centers, nursing homes, rehab centers, medical labs, and to in-home patients.

    • Baxter International Inc.: Worth A Look

      By USAStockValuation:Baxter International Inc (BAX) is a global diversified healthcare company offering a broad range of products in the fields of medical devices, pharmaceuticals as well as biotechnology. Products on offer include those that help people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and others. Baxter has manufacturing facilities in 27 countries and sells to more than 100 countries.

    • Federal Express: A Solid Buy On Any Market Pullback

      By Bret Jensen:After a massive rally in October, the market is overbought and is overdue for at least a 3%-5% selloff. In preparation of this pullback I have trimmed my long positions, initiated some new short positions last week and made a list of stocks I will deploy new money into when the markets come down some. One stock that I have targeted towards that end is Federal Express.

    • 6 Solid Reasons To Invest Into This 3% Yielder

      By Bret Jensen:Given the recent volatility in the market and the ongoing turmoil in Europe, investing in companies with solid and growing dividend yields, low valuations and consistent earnings streams makes good investment sense. One stock that fits these criteria right now is Time Warner (TWX).

    • Corning: Rock Bottom Valuation And On The Verge Of A Turnaround

      By Bret Jensen:The last few months have decimated whole sectors of the stock market (cyclicals, materials, energy, semis, etc.). One stock has had been particularly hard hit but is on the verge of a turnaround of fortune is Corning.Corning (GLW) – “Corning Incorporated manufactures and processes specialty glass and ceramics products worldwide.

    • 20% Pullback Offers Good Entry Point For This Cheap Cash Rich Tech Stock

      By Bret Jensen: Radware (RDWR) has sunk about 20% since Juniper Networks (JNPR) announced a $75mm

    • Looking To Pick Up Oil States International On Any Significant Pullback

      By Bret Jensen:It should be an interesting day in the markets on Monday as a deeply disappointing jobs report, rising yields on Spanish debt again and Egan Jones' downgrade of U.S. Government Debt hit investors' confidence. It is times like this I am happy I have a solid amount of dry powder available to deploy and my short positions should keep my portfolio less volatile than the overall market.

    Latest

    An increasingly paranoid Julian Assange remains in Equadorean embassy one year later
    An increasingly paranoid Julian Assange remains...
    George Osborne: economy is 'out of intensive care'
    George Osborne: economy is 'out of intensive...

    User login

    • Create new account
    • Request new password
    • Click on the icon to sign in with your social network login or enter your Bullfax.com login

    Our Blog

    • Oil Prices, India’s Inflation, Panama Canal and Bank Lending in Our News for Today 06/14/2013
    • SoftBank: Sprint to the finish
    • Royal Bank of Scotland, World Bank, European Stocks and Apple in Our Daily Round-Up for 06/13/2013

    Markets Map

    Markets Map

    Follow Us

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS
    S&P 500: 1628.93 -1.4% FTSE: 6348.82 -0.4% Nikk.: 13014.58 -1.77% DAX: 8197.08 -0.4% HSI: 20445.99 -2.65% FX: EUR/GBP: 1.165 USD/EUR: 1.3266 JPY/USD: 97.035 Commodities: Gold: 1343.85

    Bullfax.com - Market News & Analysis 2008-2011
    Contact Us | About Us | Terms & Conditions

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS .

    Secondary menu

    • Latest News
    • Top Rated
    • Most Popular
    • Archive
    • Discussions